v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024   27,518,439      
Beginning balance at Dec. 31, 2024 $ 204,084 $ 1 $ 348,901 $ (145,014) $ 196
Stockholders' Deficit          
Exercise stock options (in shares)   11,630      
Exercise of stock options 44   44    
Unrealized loss on marketable securities (73)       (73)
Vesting of early exercised stock options (in shares)   5,594      
Vesting of early exercised stock options 19   19    
Share-based compensation 2,555   2,555    
Net loss (14,619)     (14,619)  
Ending balance (in shares) at Mar. 31, 2025   27,535,663      
Ending balance at Mar. 31, 2025 192,010 $ 1 351,519 (159,633) 123
Beginning balance (in shares) at Dec. 31, 2024   27,518,439      
Beginning balance at Dec. 31, 2024 204,084 $ 1 348,901 (145,014) 196
Stockholders' Deficit          
Unrealized loss on marketable securities (158)        
Net loss (29,531)        
Ending balance (in shares) at Jun. 30, 2025   28,500,122      
Ending balance at Jun. 30, 2025 206,365 $ 1 380,871 (174,545) 38
Beginning balance (in shares) at Mar. 31, 2025   27,535,663      
Beginning balance at Mar. 31, 2025 192,010 $ 1 351,519 (159,633) 123
Stockholders' Deficit          
Exercise stock options (in shares)   29,003      
Exercise of stock options 196   196    
Unrealized loss on marketable securities (85)       (85)
Vesting of early exercised stock options (in shares)   5,593      
Vesting of early exercised stock options 19   19    
Share-based compensation 2,845   2,845    
Issuance of common stock through at-the-market offerings, net of issuance costs (in shares)   920,500      
Issuance of common stock through at-the-market offerings, net of issuance costs 26,067   26,067    
Exercise of stock warrant (in shares)   271      
Issuance of common stock under employee stock purchase plan (in shares)   9,092      
Issuance of common stock under employee stock purchase plan 225   225    
Net loss (14,912)     (14,912)  
Ending balance (in shares) at Jun. 30, 2025   28,500,122      
Ending balance at Jun. 30, 2025 $ 206,365 $ 1 380,871 (174,545) 38
Beginning balance (in shares) at Dec. 31, 2025 31,344,782 31,344,782      
Beginning balance at Dec. 31, 2025 $ 284,339 $ 1 511,237 (227,141) 242
Stockholders' Deficit          
Exercise stock options (in shares)   2,698      
Exercise of stock options 14   14    
Unrealized loss on marketable securities (692)       (692)
Vesting of restricted stock units (in shares)   6,914      
Share-based compensation 4,319   4,319    
Net loss (41,488)     (41,488)  
Ending balance (in shares) at Mar. 31, 2026   31,354,394      
Ending balance at Mar. 31, 2026 $ 246,492 $ 1 515,570 (268,629) (450)
Beginning balance (in shares) at Dec. 31, 2025 31,344,782 31,344,782      
Beginning balance at Dec. 31, 2025 $ 284,339 $ 1 511,237 (227,141) 242
Stockholders' Deficit          
Unrealized loss on marketable securities (871)        
Net loss $ (73,406)        
Ending balance (in shares) at Jun. 30, 2026 31,416,892 31,416,892      
Ending balance at Jun. 30, 2026 $ 219,262 $ 1 520,437 (300,547) (629)
Beginning balance (in shares) at Mar. 31, 2026   31,354,394      
Beginning balance at Mar. 31, 2026 246,492 $ 1 515,570 (268,629) (450)
Stockholders' Deficit          
Unrealized loss on marketable securities (179)       (179)
Share-based compensation 4,472   4,472    
Issuance of common stock under employee stock purchase plan (in shares)   62,498      
Issuance of common stock under employee stock purchase plan 395   395    
Net loss $ (31,918)     (31,918)  
Ending balance (in shares) at Jun. 30, 2026 31,416,892 31,416,892      
Ending balance at Jun. 30, 2026 $ 219,262 $ 1 $ 520,437 $ (300,547) $ (629)